Glycans are complex sugar molecules that play a crucial role in the communication of human cells, their response to the immune system and their operation. Human cells produce glycans using special enzymes called glycosyltransferases. In cancer, however, some of these enzymes become excessively active, which helps cancerous cells to spread and hide from the body’s defence mechanisms.
Researchers have found that blocking these overly active enzymes can slow down or even stop cancerous cells. Research presented as part of this event focuses on the development of medicines that could target these enzymes, which offers new opportunities for treating cancer.
The event is being prepared for you by Natan Koraj (UL FFA).
The event will be held in English.
The event will present the project GlyCanDrug – A training network on the design of precision therapeutics that target key glycan motifs implicated in cancer.